Sprinklr, Inc. Class A Common Stock (NY:CXM)
6.005
+0.055
(+0.92%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Mar 19, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 2,316,509 |
| Open | 5.970 |
| Bid (Size) | 6.000 (20,100) |
| Ask (Size) | 6.010 (14,500) |
| Prev. Close | 5.950 |
| Today's Range | 5.895 - 6.180 |
| 52wk Range | 5.120 - 9.400 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Why Sprinklr Stock Rocked the Market on Wednesday ↗
March 11, 2026
Sprinklr’s (NYSE:CXM) Q4 CY2025 Sales Beat Estimates
March 11, 2026
3 Reasons CXM is Risky and 1 Stock to Buy Instead
February 23, 2026
1 Russell 2000 Stock with Exciting Potential and 2 We Find Risky
February 22, 2026
3 Stocks Under $10 with Questionable Fundamentals
February 12, 2026
3 Small-Cap Stocks with Warning Signs
February 08, 2026
3 Value Stocks We Approach with Caution
February 05, 2026
1 Oversold Stock Primed to Rebound and 2 Facing Challenges
January 25, 2026
Frequently Asked Questions
Is Sprinklr, Inc. Class A Common Stock publicly traded?
Yes, Sprinklr, Inc. Class A Common Stock is publicly traded.
What exchange does Sprinklr, Inc. Class A Common Stock trade on?
Sprinklr, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Sprinklr, Inc. Class A Common Stock?
The ticker symbol for Sprinklr, Inc. Class A Common Stock is CXM on the New York Stock Exchange
What is the current price of Sprinklr, Inc. Class A Common Stock?
The current price of Sprinklr, Inc. Class A Common Stock is 6.005
When was Sprinklr, Inc. Class A Common Stock last traded?
The last trade of Sprinklr, Inc. Class A Common Stock was at 03/19/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.